Skip to main content
SpringerLink
Log in

Association of the matrix metalloproteinase-3 (−439C/G) promoter polymorphism with Kawasaki disease in Korean children

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Kawasaki disease (KD) is a multisystemic vasculitis that often includes coronary artery involvement. The serum levels of matrix metalloproteinase (MMP)-3 and-9 are significantly elevated in KD patients, and polymorphisms in the genes encoding MMP-3 and MMP-9 have been associated with the susceptibility, severity, and progression of atherosclerosis and aneurysm. However, the association between MMP-3 gene polymorphisms and development of aneurysm is somewhat controversial in a number of diseases. Ninety-seven children with KD and 194 children with congenital heart disease (CHD) were included in this study. Echocardiography was used to examine all children in the KD group for coronary artery aneurysm. Genotyping of the MMP-3 (−439C/G) promoter polymorphism was performed using the single-base extension method, and serum MMP-3 levels were estimated using the sandwich enzyme immunoassay method. There was no significant difference in MMP-3 (−439C/G) genotypes between KD and control groups. There was no association between this MMP-3 polymorphism and development of coronary aneurysm in KD. Serum MMP-3 levels were significantly higher in KD patients compared to control subjects. Among the KD patients, serum MMP-3 levels were higher in children with genotypes CG+GG compared to the CC group, but this difference was not significant. Although further large-scale studies will be required to fully examine the relationship between MMP-3 gene polymorphisms and coronary artery lesions (CAL) in KD, the present findings suggest that while MMP-3 may play a role in the pathogenesis of KD, there is no apparent association between CAL and the MMP-3 (−439C/G) gene polymorphism in Korean children with KD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Matsuura K, Kobayashi J, Bando K, Niwaya K, Tagusari O, Nakajima H, Kitamura S (2006) Redo off-pump coronary bypass grafting with arterial grafts for Kawasaki disease. Heart Vessels 21:361–364

    Article  PubMed  Google Scholar 

  2. Takeshita S, Tokutomi T, Kawase H, Nakatani K, Tsujimoto H, Kawamura Y, Sekine I (2001) Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease. Clin Exp Immunol 125:340–344

    Article  PubMed  CAS  Google Scholar 

  3. Johnson LL, Dyer R, Hupe DJ (1998) Matrix metalloproteinases. Curr Opin Chem Biol 2:466–471

    Article  PubMed  CAS  Google Scholar 

  4. Gruber BL, Sorbi D, French DL, Marchese MJ, Nuovo GJ, Kew RR, Arbeit LA (1996) Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker. Clin Immunol Immunopathol 78:161–171

    Article  PubMed  CAS  Google Scholar 

  5. Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM (1995) Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation 91:2125–2131

    PubMed  CAS  Google Scholar 

  6. Yoon S, Tromp G, Vongpunsawad S, Ronkainen A, Juvonen T, Kuivaniemi H (1999) Genetic analysis of MMP-3, MMP-9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 265:563–568

    Article  PubMed  CAS  Google Scholar 

  7. Hovsepian DM, Ziporin SJ, Sakurai MK, Lee JK, Curci JA, Thompson RW (2000) Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease. J Vasc Interv Radiol 11:1345–1352

    Article  PubMed  CAS  Google Scholar 

  8. McMillan WD, Pearce WH (1999) Increased plasma levels of metalloproteinase 9 are associated with abdominal aortic aneurysms. J Vasc Surg 29:122–129

    Article  PubMed  CAS  Google Scholar 

  9. Ye S (2000) Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 19:623–629

    Article  PubMed  CAS  Google Scholar 

  10. Chua PK, Melish ME, Yu Q, Yanagihara R, Yamamoto KS, Nerurkar VR (2003) Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease. Clin Diagn Lab Immunol 10:308–314

    Article  PubMed  CAS  Google Scholar 

  11. Senzaki H, Masutani S, Kobayashi J, Kobayashi T, Nakano H, Nagasaka H, Sasaki N, Asano H, Kyo S, Yokote Y (2001) Circulating matrix metalloproteinase and their inhibitors in patients with Kawasaki disease. Circulation 104:860–863

    Article  PubMed  CAS  Google Scholar 

  12. Gavin PJ, Crawford SE, Shulman ST, Garcia FL, Rowley AH (2003) Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease. Arterioscler Thromb Vasc Biol 23:576–581

    Article  PubMed  CAS  Google Scholar 

  13. Cho AR, Hong YM (2004) Matrix metalloproteinase, tissue inhibitors and cytokines in patients with Kawasaki disease. Korean J Pediatr 47:656–664

    Google Scholar 

  14. Lamblin N, Bauters C, Hermant X, Lablanche JM, Helbecque N, Amouyel P (2002) Polymorphisms in promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurismal coronary artery disease. J Am Coll Cardiol 40:43–48

    Article  PubMed  CAS  Google Scholar 

  15. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM (1996) Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. Biol Chem 271:13055–13060

    Article  CAS  Google Scholar 

  16. Park JA, Shin KS, Kim YW (2005) Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease. J Korean Med Sci 20:607–611

    Article  PubMed  CAS  Google Scholar 

  17. Japanese Kawasaki Disease Research Committee (1984) Diagnostic guidelines of Kawasaki disease, 4th edn. Japan Kawasaki Disease Research Committee, Tokyo

    Google Scholar 

  18. Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM (1995) Preliminary report: Genetic variation in human stromelysin gene promoter is associated with progression of atherosclerosis. Br Heart J 73:209–215

    Article  PubMed  CAS  Google Scholar 

  19. Samnegard A, Silveira A, Lundman P, Boquist S, Odeberg J, Hulthe J, McPheat W, Tornvall P, Bergstrand L, Ericsson CG, Hamsten A, Eriksson P (2005) Serum matrix metalloproteinase-3 concentration is influenced by MMP-3-1612 5A/6A promoter genotype and associated with myocardial infarction. J Intern Med 258:411–419

    Article  PubMed  CAS  Google Scholar 

  20. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM (1996) Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 271:13055–13060

    Article  PubMed  CAS  Google Scholar 

  21. Humphries S, Bauters C, Meirhaeghe A, Luong L, Bertrand M, Amouyel P (2002) The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene as a risk factor for restenosis. Eur Heart J 23:721–725

    Article  PubMed  CAS  Google Scholar 

  22. Biezeveld MH, van Mierlo G, Lutter R, Kuipers IM, Dekker T, Hack CE, Newburger JW, Kuijpers TW (2005) Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases. Clin Exp Immunol 141: 183–188

    Article  PubMed  CAS  Google Scholar 

  23. Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S (2000) Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease. J Pediatr 137:77–80

    Google Scholar 

  24. Matsuyama T (1999) Tissue inhibitor of metalloproteinases-1 and matrix metalloproteinase-3 in Japanese healthy children and in Kawasaki disease and their clinical usefulness in juvenile rheumatoid arthritis. Pediatr Int 41:239–245

    Article  PubMed  CAS  Google Scholar 

  25. Senzaki H (2006) The pathogenesis of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases. Arch Dis Child 91:847–851

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, School of Medicine, Ewha Womans University, 911-1 MokDong, YangCheon-ku, Seoul, 158-710, Republic of Korea

    Young Mi Hong

  2. Department of Pediatrics, School of Medicine, Ulsan University, Seoul, Republic of Korea

    Hyun-Seung Jin, In Sook Park & Soo-Jong Hong

Authors
  1. Young Mi Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hyun-Seung Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. In Sook Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Soo-Jong Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Young Mi Hong.

Additional information

Young Mi Hong and Soo-Jong Hong contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hong, Y.M., Jin, HS., Park, I.S. et al. Association of the matrix metalloproteinase-3 (−439C/G) promoter polymorphism with Kawasaki disease in Korean children. Heart Vessels 23, 341–347 (2008). https://doi.org/10.1007/s00380-008-1041-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-008-1041-1

Key words

Search

Navigation